Anixa Biosciences (ANIX) Consolidated Net Income (2010 - 2026)
Anixa Biosciences' Consolidated Net Income was -$2.63 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$2.28 million a year earlier.
Powered by 
Analysis
Anixa Biosciences (ANIX) Consolidated Net Income (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Anixa Biosciences' Consolidated Net Income was -$10.16 million through Jul 31, 2026; for FY2025 (ended Oct 31, 2025), it was -$11.03 million.
- In earlier fiscal years, Consolidated Net Income was -$12.7 million in FY2024, -$9.93 million in FY2023, -$13.77 million in FY2022 and -$13.13 million in FY2021.
- Quarterly Consolidated Net Income has moved between -$4.07 million (fiscal Q4 2021) and -$2.28 million (fiscal Q3 2025) over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Anixa Biosciences | 102.02 Mn | 100.75 Mn | - | -2.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -2.63 Mn |
| Apr 30, 2026 | -2.54 Mn |
| Oct 31, 2025 | -2.72 Mn |
| Jul 31, 2025 | -2.28 Mn |
| Apr 30, 2025 | -2.81 Mn |
| Jan 31, 2025 | -3.21 Mn |
| Oct 31, 2024 | -2.91 Mn |
| Jul 31, 2024 | -3.32 Mn |
| Apr 30, 2024 | -3.18 Mn |
| Jan 31, 2024 | -3.29 Mn |
| Oct 31, 2023 | -2.72 Mn |
| Jul 31, 2023 | -2.55 Mn |
| Apr 30, 2023 | -2.31 Mn |
| Jan 31, 2023 | -2.35 Mn |
| Oct 31, 2022 | -3.53 Mn |
| Jul 31, 2022 | -2.78 Mn |
| Apr 30, 2022 | -3.59 Mn |
| Jan 31, 2022 | -3.88 Mn |
| Oct 31, 2021 | -4.07 Mn |
| Jul 31, 2021 | -4.39 Mn |
API Access
Anixa Biosciences Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();